S961: Mechanism of Action

S961 MOA:Targeting Insulin Receptor/PI3K-AKT Pathway for Diabetes and Metabolic Syndrome

🎯 check S961 product page

S961 is a potent peptide insulin receptor antagonist. It affects PI3K/AKT and MAPK signaling by blocking the InsR signaling cascade, effectively inhibiting insulin-induced cell proliferation and colony formation.

Primary Applications and Mechanism of Action